APLS Apellis Pharmaceuticals, Inc.
$41.03▲ +0.00%
Unknown
Other
Volume 28.64M
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
$5.25B
P/E Ratio
38.3
Div Yield
–%
52W Range
16.61 - 41.14
% vs 50 MA
23.59%
% vs 200 MA
57.34%
RSI-14
84.5
MACD Histogram
-0.6000
Beta (1Y vs SPY)
4.57
Free Cash Flow
-$60.97M
Gross Rev
$268.30M
Gross Profit
$227.75M
EBITDA
$29.76M
COGS
$40.55M
Operating Exp
$201.28M
Operating Income
$26.47M
EBIT
$26.47M
Pretax Income
$19.15M
Net Income
$18.66M
EPS (Diluted)
0.15
Price & Volume History
Loading chart…
Recent News
No recent news found for APLS.
Financial Overview - Income Statement
Quarterly
Mar 2026
See APLS's money flow as a full page
Social Sentiment
Avg +0.80 · 2 posts
NewsTradeMarket Close Report - Tuesday, March 31, 2026
r/investing · Mar 31, 2026
Large percentage increase suggests strong positive sentiment.
very_positive
+1.00
NewsDDAPLS
r/wallstreetbets · Jul 29, 2025
FDA approval is a significant catalyst and generally viewed positively for the stock.
positive
+0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.